HIFU Treatment Gains Momentum
Dr. Tracy Gapin of Sarasota Prostate continues to break barriers with the latest technology for prostate cancer.
"At Sarasota Prostate, we are excited to provide HIFU as an additional option to the traditional treatments of prostate cancer."
MIAMI, FL, UNITED STATES, May 27, 2016 /EINPresswire.com/ -- Dr. Tracy Gapin of Sarasota, Florida continues to break barriers when it comes to utilizing the latest technology for the treatment of prostate cancer. Late last year the FDA cleared the way for HIFU to used to ablate the prostate tissue. This ablation may be applied for prostate therapy. — Dr. Tracy Gapin
Multi-institutional prospective studies have yielded consistent results showing that treatment with HIFU (High Intensity Focused Ultrasound) leads to the eradication of all medically significant cancer tissues in the parts that get treated for patients with early stage prostate cancer with a 94% success rate.
Out of 101 investigated cases, HIFU resulted in total cancer removal in the treated parts for 87 cases, which is an 86% success rate. In addition, 68 of the investigated cases, showed no cancer in the entire prostate – including prostate areas that weren’t treated. 89% of the investigated persons remained alive and well without having to undergo radical therapy after two years of monitoring and follow up. One year after administering HIFU, nearly all patients were able to control their bladders and urinate properly once again. Furthermore, erectile function was well-preserved in 80 percent of the men who had HIFU.
Lead researcher Pascal Rischman, PhD and chairperson of urology at Toulouse’s Rangueil University Hospital in France said that HIFU greatly reduces or eliminates cancer and has tolerable rate of side effects. Rischman added that their research confirmed HIFU preserves the quality of life. According to Rischman, the use of HIFU offers a “dependable alternative to the traditional whole-gland pervasive procedures done to some patients having intermediate risk cancer”.
The findings of the study were given during the American Urological Association (AUA) 2016 meeting which demonstrated the effectiveness of HIFU in treating low risk and intermediate risk prostate cancer. The traditional radical treatments yield reproachable benefits to low and intermediate risk patients and are also said to put patients at a greater risk of possible functional consequences.
HIFU has many advantages compared to the traditional methods of treating low-risk and intermediate-risk cancer. These advantages include:
· Minimal recovery period
· Results of little to no blood loss
· Minimal side effects linked to the treatment
· It can be repeated
· It is an outpatient procedure and patients are not hospitalized at any time.
· Patients are able to resume normal lifestyle in a matter of few days
· Zero radiation effect
· Can be a applied as a last resort method of treating prostate cancer where other procedures have failed
· Highly effective cancer treatment
Over 40,000 men from across the globe have successfully recovered from localized prostate cancer through HIFU treatment which gives excellent results, has negligible occurrence of side effects and enables quick recovery. Over 7,000 men from the United States had gone outside the country to get HIFU before it was cleared by the FDA. Presently, HIFU is a FDA-certified technique for removing diseased prostate tissue and is effectively done at places like the Sarasota Prostate Care, in Sarasota, Florida.
The Florida based Sarasota Prostate Care was founded and is directed by Dr. Tracy Gapin and is a post-modern treatment center focused on giving patients compassionate care and at the same time using revolutionary technology in prostate cancer diagnosis and therapy using minimally invasive treatment such as HIFU. Dr. Gapin is an urologist of many firsts including being the very first surgeon to perform Da Vinci prostatectomy in Sarasota and has undertaken more than 300 successful surgeries using this one-of-a-kind robot guided technology.
Keith Schilling
Creative Behavior
7042698765
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.